Compare Illumina, Inc. (ILMN) vs Kroger Co (KR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Kroger Co — how do they compare? Illumina, Inc. trades at $265 (market cap $40.43B), while Kroger Co trades at $61.26 (market cap $34.99B). The key difference: Illumina, Inc. is the larger of the two by market cap, and Kroger Co pays a 2.63% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and Kroger Co for 108 Days on average.
| ILMN | KR | |
|---|---|---|
Market Cap | $40.43B | $34.99B |
Volume | 2,948,626 | 8,938,607 |
Sector | Health | Consumer Staples |
52-Week High | $293.69 | $75.60 |
52-Week Low | $91.00 | $55.53 |
Typical Hold Time | 83 Days | 108 Days |
Enterprise Value | $41.79B | $56.41B |
Dividend Yield | — | 2.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $264.40, down 3.34% on the day but up significantly year-to-date with strong technical momentum. The stock shows bullish moving average signals and trades near pivot point resistance at $268. Fundamentally, the company has delivered three consecutive quarterly earnings beats and returned to profitability in 2025 with $850 million net income after previous losses. Recent catalysts include S&P 500 inclusion effective September 21, 2026, and growing AI integration in genomics applications.
The outlook remains positive with analyst consensus favoring Buy ratings (54%) and a $241 price target, though current price exceeds consensus. Key opportunities include sequencing growth and AI-driven biological data expansion, while risks involve China market headwinds and elevated valuation multiples. Earnings growth and S&P 500 inclusion provide near-term catalysts, but the stock trades at premium valuations with P/E of 49.96 requiring sustained execution.
Kroger (KR) trades at $61.41, up 5.14% today, with a bullish technical signal from moving averages. The stock shows strong fundamentals with $147.12B in revenue, though net margins remain thin at 0.73%. Recent earnings show mixed results with Q2 2026 beating expectations but Q1 2026 missing. The company maintains positive cash flow generation and continues dividend payments while facing competitive pressures in the grocery sector.
Kroger presents a balanced investment case with attractive valuation metrics (P/S 0.25) and analyst consensus pointing to 15% upside to $70.62 target. However, risks include integration challenges from acquisitions, margin pressure from price competition, and softer 2026 sales guidance. The stock offers value characteristics with dividend yield support amid ongoing digital transformation efforts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Kroger Co
Kroger is the leading American grocer, with 2,726 supermarkets operating under several banners throughout the country as of the end of fiscal 2021. Around 83% of stores have pharmacies, while nearly 60% also sell fuel. The company also operates roughly 120 fine jewelry stores. Kroger features a leading private-label offering and manufactures around 30% of its own-brand units (and more than 40% of its grocery own-label assortment) itself, in 33 food production plants nationwide. Kroger is a top-two grocer in most of its major markets (as of early 2021, according to company data). Virtually all of Kroger's sales come from the United States.
Read more on KR →
